AtriCure (NSDQ:ATRC) shares took a fall today despite preliminary results for the fourth quarter and 2018 that topped estimates. The Mason, Ohio-based cardiac implant maker said it expects to post Q4 sales of $52.9 million and 2018 sales of $201.6 million, beating the consensus estimatyes on Wall Street for both periods. “We are pleased with our […]
OrthoPediatrics announces pricing of common stock offering
OrthoPediatrics (NSDQ:KIDS) said today it will price an underwritten follow-on public offering of 1.5 million shares of its common stock at $27 per share. The company said it plans to use the proceeds of offering to invest in implant and instrument sets for consignment to its customers, fund research and development activities, expand its sales and […]
OrthoPediatrics expands Indiana-based headquarters
OrthoPediatrics said yesterday it is planning a $1 million expansion of its Warsaw, Ind.-based headquarters, looking to double its warehouse space and add administrative spaces. The expansion will include the addition of open-concept offices and dedicated training and education facilities, the company said. A ground-breaking on the expansion is being held on August 16. “Indiana is […]
OrthoPediatrics announces Femur pediatric nailing platform FDA nod, Q1 earnings
OrthoPediatrics this week announced it won FDA 510(k) clearance for its Femur pediatric nailing platform and released its first quarter earnings, beating sales consensus but missing on loss-per-share expectations on Wall Street. The Warsaw, Ind.-based company’s Femur system is designed to accompany two pediatric-specific nail offerings, and is an upgrade to an earlier version of the […]
OrthoPediatrics launches pediatric wrist fusion plate
OrthoPediatrics said yesterday it launched its pediatric-specific wrist fusion plate system as part of its PediFrag franchise. The wrist fusion plate system includes plates in two implant lengths to accomodate patients with and without proximal row carpectomies and features low-profile stainless steel plates to minimize plate prominence and reduce soft-tissue irritation, the Warsaw, Ind.-based company said. […]
OrthoPediatrics prices $52m IPO
OrthoPediatrics today priced its initial public offering at $13 per share, meaning the 4-million-share flotation pulled in $52 million for its line of surgical systems for children. The offering includes a 30-day underwriters over-allotment of 600,000 extra shares, which if fully exercised would push the IPO’s total raise to $59.8 million. Warsaw, Ind.-based OrthoPediatrics produces 21 surgical […]
OrthoPediatrics sets price range on IPO, could bring in up to $64m
OrthoPediatrics yesterday priced the range on its initial public offering, looking to float 4 million shares of common stock at between $12 and $14 per share, which would bring in between $48 and $56 million. The offering also includes a 30-day underwriter’s option to purchase an additional 600,000 shares of common stock, bringing the possible […]
OrthoPediatrics files for $58m IPO
OrthoPediatrics said this week it filed for an initial public offering, looking to bring in $57.5 million for the company and its pediatric-focused orthopedic device offering. The Warsaw, Ind.-based company said it plans to list on the NASDAQ exchange under the “KIDS” symbol, but has not determined what number of shares will be offered or […]
OrthoPediatrics registers $75m IPO
OrthoPediatrics, which says it is the only medical device company exclusively devoted to orthopedic implants for children, this week registered for an initial public offering worth $75 million. Based in the orthopedics hotbed of Warsaw, Ind., OrthoPediatrics plans to list on the NASDAQ exchange under the “KIDS” symbol. The company counts Squadron Capital among its […]
Ex-Insulet CFO Roberts lands at Avedro | Personnel Moves
ETEX Corp. inks distribution deal with OrthoPediatrics Corp.
ETEX Corp. inked a non-exclusive deal with an Indiana company to distribute a bone putty used in spinal fusion treatments.
OrthoPediatrics Corp. will sell the Cambridge, Mass.-based company’s nanocrystalline calcium phosphate into the pediatric market in the U.S. and Canada. The product is used in spinal fusion procedures to fill bone voids or skeletal defects "that are not intrinsic to the stability of the bone structure," according to a press release.
MassDevice Network
@MassDevice
LinkedIn
YouTube